Literature DB >> 18769861

Computer-aided visualization of muscle weakness distribution.

Allan J Pieterse1, Nicol C Voermans, Hans S Tuinenga, Baziel G M van Engelen.   

Abstract

We present a computer program for visualizing muscle weakness distribution in patients with neuromuscular disorders. Ordinal muscle strength data can be computed in the program. Data are visualized as the prime movers of the testmovements in an image of the human body and a separate image of the face. Severity is indicated in shades of grey and black indicates complete loss of muscle power. This visualization facilitates the diagnosis and follow-up of patients and is an excellent tool for patient education. Moreover, the program can also be used to investigate and further refine the phenotypic description of these disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18769861     DOI: 10.1007/s00415-008-0959-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

Authors:  M C Dalakas; B Koffman; M Fujii; S Spector; K Sivakumar; E Cupler
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

2.  The clinical spectrum of neuralgic amyotrophy in 246 cases.

Authors:  Nens van Alfen; Baziel G M van Engelen
Journal:  Brain       Date:  2005-12-21       Impact factor: 13.501

3.  On the classification, natural history and treatment of the myopathies.

Authors:  J N WALTON; F J NATTRASS
Journal:  Brain       Date:  1954       Impact factor: 13.501

Review 4.  The muscular dystrophies.

Authors:  A E Emery
Journal:  BMJ       Date:  1998-10-10

Review 5.  Dystroglycan: important player in skeletal muscle and beyond.

Authors:  Ronald D Cohn
Journal:  Neuromuscul Disord       Date:  2005-01-28       Impact factor: 4.296

6.  The McGill Pain Questionnaire: major properties and scoring methods.

Authors:  Ronald Melzack
Journal:  Pain       Date:  1975-09       Impact factor: 6.961

Review 7.  The muscular dystrophies.

Authors:  Alan E H Emery
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

8.  Autosomal recessive oculopharyngodistal myopathy: a distinct phenotypical, histological, and genetic entity.

Authors:  B M van der Sluijs; H J ter Laak; H Scheffer; S M van der Maarel; B G M van Engelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

9.  Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial.

Authors:  E Lindeman; P Leffers; F Spaans; J Drukker; J Reulen; M Kerckhoffs; A Köke
Journal:  Arch Phys Med Rehabil       Date:  1995-07       Impact factor: 3.966

Review 10.  Muscular dystrophy into the new millennium.

Authors:  Alan E H Emery
Journal:  Neuromuscul Disord       Date:  2002-05       Impact factor: 4.296

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.